Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774836 · ClinicalTrials.gov registry record · Phase 3
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
A Phase 3 study of Pain Management, sponsored by Avenue Therapeutics.
- Active
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
- 3
- Study locations
NCT03774836: Active Phase 3 study of Pain Management, sponsored by Avenue Therapeutics.
NCT03774836 is a Phase 3 study of Pain Management that is active but no longer recruiting, run by Avenue Therapeutics. The registered enrollment target is 360 participants, above the 143-participant average among 31 other Pain Management trials with a reported enrollment target (152% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03774836, a Phase 3 study of Pain Management, is active but no longer recruiting, sponsored by Avenue Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is evaluating the analgesic efficacy of intravenous (IV) tramadol (AVE-901) compared to placebo in the management of postoperative pain following abdominal surgery.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Morphine
- DRUG Tramadol
Study Locations (3)
Texas
- Hermann Drive Research - Houston
- Endeavor Clinical Trials - San Antonio
California
- Lotus Clinical Research - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2018-12-14 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 3 |
What the registry record for NCT03774836 still lists
NCT03774836 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, above the 143-participant average among 31 other Pain Management trials with a reported enrollment target (152% higher).
The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03774836 reports a single indexed study location in Texas, California.
Frequently Asked Questions
What is clinical trial NCT03774836 about?
NCT03774836 is a clinical study titled "Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty". This study is evaluating the analgesic efficacy of intravenous (IV) tramadol (AVE-901) compared to placebo in the management of postoperative pain following abdominal surgery.
What is the current status of trial NCT03774836?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2018-12-14. Estimated completion is 2019-06-30.
What conditions does trial NCT03774836 study?
This clinical trial studies the following conditions: Pain Management.
What interventions are being tested in trial NCT03774836?
The interventions under investigation include: Placebo (OTHER), Morphine (DRUG), Tramadol (DRUG).
Who is sponsoring clinical trial NCT03774836?
This trial is sponsored by Avenue Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03774836 being conducted?
This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03774836's enrollment target sits among peer trials
360 5th of 31 higher than 26 of 31 other Pain Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
R.E.C.K vs Exparel in Robotic Nephrectomy
RECRUITING · Phase 3
-
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
ACTIVE NOT RECRUITING · Phase 3
-
Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
COMPLETED · Phase 3
-
Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty
COMPLETED · Phase 3
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI